Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Claire Mazumdar currently holds 110,546 shares of Bicara Therapeutics Inc. (BCAX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Claire Mazumdar has been a net seller of BCAX stock. They have purchased $0 and sold $2.1M worth of shares.
Claire Mazumdar's most recent insider trade was on Aug 10, 2026, when they sold 10,000 shares at $0.00 per share.
Claire Mazumdar serves as Executive at Bicara Therapeutics Inc. (BCAX). They have executed 21 insider transactions totaling $2.1M over their tenure at the company.
Claire Mazumdar holds the position of Executive at Bicara Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Claire Mazumdar has shown a selling trading pattern, with $0 in total purchases and $2.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Claire Mazumdar was on Nov 24, 2025, when they sold $776.3K worth of BCAX shares. This transaction involved 41,163 shares at $18.86 per share.
Claire Mazumdar currently owns 110,546 shares of Bicara Therapeutics Inc. (BCAX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Claire Mazumdar's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Claire Mazumdar has 21 Form 4 filings on record as an insider at Bicara Therapeutics Inc..
Set alerts for Claire Mazumdar and 40,000+ other insiders.